MapLight Therapeutics Inc.
Organization details
- Legal name
- MapLight Therapeutics Inc.
- Former names
- Alvarado Therapeutics, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Redwood City
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MPLT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001770069
- EIN
- 83-2163243
Board of directors
-
Christopher A. Kroeger · Director · Chief Executive OfficerSince 2025
-
George Pavlov · DirectorSince 2025
-
James D. Trenkle · DirectorSince 2025
-
Maria C. Walker · DirectorSince 2025
-
Martin Babler · DirectorSince 2026
-
Nanna Liebach Luneborg · DirectorSince 2025
-
Robert C. Malenka · DirectorSince 2025
-
Timothy John Garnett · DirectorSince 2025
-
Troy Cox · DirectorSince 2026
Chief executives
Director election results
Annual meeting of June 23, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.8%
-
97.8%
-
99.9%
Board connections
3 of this board's directors also sit on 7 other boards. 5 are in the same sector.
-
Alumis Inc. Same sectorvia Martin Babler
- via Maria C. Walker
-
Neurogene Inc. Same sectorvia Martin Babler
-
Prelude Therapeutics Incorporated Same sectorvia Martin Babler
- via Troy Cox
-
Standard BioTools Inc. Same sectorvia Troy Cox
-
Zymeworks Inc. Same sectorvia Troy Cox
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $66,229,175
- 10 purchases by 4 insiders
- Sold, last 12 months
- $30,239,360
- 145 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 15, 2026 | Foff Erin Pennock Officer (Chief Medical Officer) | Open-market sale | −15,355 | $8.08 | $124,068 |
| Oct 15, 2026 | GILLIS JONATHAN Officer (CAO and Interim CFO) | Open-market sale | −10,167 | $8.08 | $82,149 |
| Oct 15, 2026 | Hanson Kristopher Officer (General Counsel) | Open-market sale | −9,020 | $8.08 | $72,882 |
| Oct 15, 2026 | Kreitzer Anatol Officer (Chief Discovery Officer) | Open-market sale | −12,248 | $7.84 | $96,024 |
| Oct 15, 2026 | Christopher A. Kroeger Director, Officer (Chief Executive Officer) | Open-market sale | −73,691 | $8.08 | $595,423 |
| Oct 15, 2026 | Lillie James Woodruff Officer (Chief Scientific Officer) | Open-market sale | −11,513 | $8.08 | $93,025 |
| Sep 16, 2026 | Hanson Kristopher Officer (General Counsel) | Open-market sale | −16,509 | $11.67 | $192,660 |
| Aug 17, 2026 | Foff Erin Pennock Officer (Chief Medical Officer) | Grant or award | +13,360 | — | — |
| Aug 17, 2026 | GILLIS JONATHAN Officer (CAO and Interim CFO) | Grant or award | +6,020 | — | — |
| Aug 17, 2026 | Hanson Kristopher Officer (General Counsel) | Grant or award | +7,730 | — | — |
| Aug 17, 2026 | Kreitzer Anatol Officer (Chief Discovery Officer) | Grant or award | +6,020 | — | — |
| Aug 17, 2026 | Christopher A. Kroeger Director, Officer (Chief Executive Officer) | Grant or award | +23,145 | — | — |
| Aug 17, 2026 | Lillie James Woodruff Officer (Chief Scientific Officer) | Grant or award | +7,730 | — | — |
| Aug 17, 2026 | GILLIS JONATHAN Officer (CAO and Interim CFO) | Grant or award | +2,222 | — | — |
| Aug 14, 2026 | Catalyst4, Inc. 10% owner | Open-market purchase | +4,400,000 | $11.38 | $50,072,000 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about MapLight Therapeutics Inc.
Who is the CEO of MapLight Therapeutics Inc.?
Christopher A. Kroeger has been MapLight Therapeutics Inc.'s Chief Executive Officer since October 2025.
How many directors are on MapLight Therapeutics Inc.'s board?
MapLight Therapeutics Inc.'s board has 9 directors: Christopher A. Kroeger, George Pavlov, James D. Trenkle, Maria C. Walker, Martin Babler, Nanna Liebach Luneborg, Robert C. Malenka, Timothy John Garnett and Troy Cox.
Are MapLight Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, MapLight Therapeutics Inc. insiders bought $66.2 million of shares in 10 purchases and sold $30.2 million of shares in 145 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="maplight-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.